No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

Author： Yao Lei  

Publisher： Springer Publishing Company

ISSN： 0167-6806

Source： Breast Cancer Research and Treatment, Vol.122, Iss.1, 2010-07, pp. : 237-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Does race modify the association between CYP1B1 Val432Leu polymorphism and breast cancer risk? A critical appraisal of a recent meta-analysis

By Economopoulos Konstantinos  

Breast Cancer Research and Treatment, Vol. 124, Iss. 1, 2010-11 ,pp. : 293-294

Springer Publishing Company

Access to resources Recommend Favorite

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 503-507

Springer Publishing Company

Access to resources Recommend Favorite

No association between CYP17 T-34C polymorphism and breast cancer risk: a meta-analysis involving 58,814 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 221-227

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association between MnSOD Val16Ala polymorphism and breast cancer risk: a meta-analysis involving 58,448 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 123, Iss. 2, 2010-09 ,pp. : 543-547

Springer Publishing Company

Access to resources Recommend Favorite

Lack of association of CYP1A2-164 A/C polymorphism with breast cancer susceptibility: a meta-analysis involving 17,600 subjects

By Qiu Li-Xin  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 521-525

Springer Publishing Company

Access to resources Recommend Favorite